Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACT Trial: Ranolazine for Crohn's Disease-associated Diarrhea
NCT04456517Phase 2Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in Crohn's disease, sponsored by Vanderbilt University Medical Center. Started Oct 2022; status: terminated.
02
Drugs
ranolazine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04456517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04456517.